ArticleJournal of the National Cancer Institute2026
Diagnostic yield of surveillance mammography among older women.
Article in Journal of the National Cancer Institute, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Surveillance mammography in older women-should we press on?Journal of the National Cancer Institute · 2026Article
Corrections and comments
- Commented on by
Authors and funding
6 authors.
Funding
Abstract
backgroundMammographic surveillance is common among older women with a history of breast cancer, but little is known about imaging outcomes in this population. The goal of this study was to describe short-term outcomes after surveillance mammography among older women, including use of subsequent imaging, cancer diagnosis, and positive predictive value.
methodsThis longitudinal cohort study used Surveillance, Epidemiology and End Results-Medicare data. We followed women diagnosed with breast cancer between 2003 and 2007 at age 67 or older until diagnosis of a second primary breast cancer, death, or end of follow-up (2019). We used claims to identify surveillance mammograms. Outcomes included subsequent imaging, second primary breast cancer diagnosis, and positive predictive value after surveillance. Outcomes were identified based on proximity to surveillance mammography. We stratified analyses by age and time since diagnosis.
resultsThe cohort included 33 607 women who received 160 637 mammograms over a median of 12.1 years. Subsequent imaging was performed after 115 per 1000 mammograms (95% confidence interval [CI] = 114 to 117) and was similar across ages and time since diagnosis. Second primary breast cancer was diagnosed after 7.1 per 1000 mammograms (95% CI = 6.7 to 7.5) and was similar across ages but generally higher beginning 5 years postdiagnosis. Positive predictive value among women with subsequent imaging ranged from 3.7% to 9.2%. Most second primary breast cancers were either in situ (23.3%) or stage I (57.0%).
conclusionsAlthough surveillance mammography may detect breast cancer even years after diagnosis, surveillance also leads to substantial subsequent testing. Whether continued surveillance at older ages improves health outcomes is uncertain.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.